【24h】

MICRO-CHANNEL HAEMO DIALYSER

机译:微通道血氧透析仪

获取原文
获取原文并翻译 | 示例

摘要

The hollow fiber based haemo dialyzer made and extremely important impact in haemo dialysis practice in the last three decades. Many people with renal diseases were able to improve their life expectancy and maintain a somewhat improved health-lifestyle. With the prospect of doubling the number of renal patients in Europe and North America by 2020, and expected improvement of health care in developing nations current dialysis treatment models and practices need new approaches and above all new technical solutions. It appears that the hollow fiber technology has met technical limitations in further development of dialysis practices. The most obvious limitations are: i) high flow rate of dialysate with respect to blood flow rate and associated cost of dialysate, ii) inability to scale down the size of the hollow fiber dialyzer for pediatric use, or everyday nocturnal dialysis in adults without dramatic reduction of dialyzer efficiency, and iii) inability to increase the overall mass transfer rate and thus reduce the cost of both dialyzer and dialysate used. MicroChannel haemo dialyzers with flat membranes, developed at Oregon State University, holds many promises that are pertinent to the needs of renal patients and healthcare providers.
机译:在过去的三十年中,基于中空纤维的血液透析器在血液透析实践中产生了极其重要的影响。许多患有肾脏疾病的人能够提高预期寿命,并保持一定程度的健康生活方式。到2020年,欧洲和北美的肾病患者人数有望增加一倍,并有望改善发展中国家的医疗保健水平。目前的透析治疗模式和实践需要新的方法,尤其是新的技术解决方案。似乎中空纤维技术在透析实践的进一步发展中遇到了技术限制。最明显的局限性是:i)相对于血液流速的高透析液流速和相关的透析液成本,ii)无法缩小中空纤维透析器的尺寸以用于儿科,或成年人的夜间睡眠透析而无严重并发症降低透析器效率,以及iii)无法提高整体传质速率,从而降低透析器和透析液的使用成本。俄勒冈州立大学开发的带有扁平膜的微通道血液透析器具有许多与肾脏病患者和医疗保健提供者的需求相关的承诺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号